75 related articles for article (PubMed ID: 7733333)
1. Effect of peptide YY on human renal function.
Playford RJ; Mehta S; Upton P; Rentch R; Moss S; Calam J; Bloom S; Payne N; Ghatei M; Edwards R
Am J Physiol; 1995 Apr; 268(4 Pt 2):F754-9. PubMed ID: 7733333
[TBL] [Abstract][Full Text] [Related]
2. Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide.
Playford RJ; Benito-Orfila MA; Nihoyannopoulos P; Nandha KA; Cockcroft J; Todd S; Ghatei MA; Domin J; Bloom SR; Calam J
Am J Physiol; 1992 Oct; 263(4 Pt 1):E740-7. PubMed ID: 1415694
[TBL] [Abstract][Full Text] [Related]
3. Effects of peptide YY and neuropeptide Y on gastric emptying in man.
Allen JM; Fitzpatrick ML; Yeats JC; Darcy K; Adrian TE; Bloom SR
Digestion; 1984; 30(4):255-62. PubMed ID: 6548978
[TBL] [Abstract][Full Text] [Related]
4. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
5. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
6. Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man.
Adrian TE; Sagor GR; Savage AP; Bacarese-Hamilton AJ; Hall GM; Bloom SR
J Clin Endocrinol Metab; 1986 Oct; 63(4):803-7. PubMed ID: 3755728
[TBL] [Abstract][Full Text] [Related]
7. Effect of peptide YY on gastric, pancreatic, and biliary function in humans.
Adrian TE; Savage AP; Sagor GR; Allen JM; Bacarese-Hamilton AJ; Tatemoto K; Polak JM; Bloom SR
Gastroenterology; 1985 Sep; 89(3):494-9. PubMed ID: 3839479
[TBL] [Abstract][Full Text] [Related]
8. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers.
Savage AP; Adrian TE; Carolan G; Chatterjee VK; Bloom SR
Gut; 1987 Feb; 28(2):166-70. PubMed ID: 3557189
[TBL] [Abstract][Full Text] [Related]
9. Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors.
Corp ES; Melville LD; Greenberg D; Gibbs J; Smith GP
Am J Physiol; 1990 Aug; 259(2 Pt 2):R317-23. PubMed ID: 2386243
[TBL] [Abstract][Full Text] [Related]
10. Effects of intraluminal peptide YY on pancreatic function.
Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
Int J Pancreatol; 1992 Oct; 12(2):153-60. PubMed ID: 1460330
[TBL] [Abstract][Full Text] [Related]
11. Experimental studies on the interrelationship between organs mediated by peptide YY: effect on splanchnic circulation and exocrine pancreas in dogs.
Sumi S; Inoue K; Tobe T
Nihon Geka Hokan; 1990 May; 59(3):224-33. PubMed ID: 2130785
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
[TBL] [Abstract][Full Text] [Related]
13. Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders.
Liu CD; Aloia T; Adrian TE; Newton TR; Bilchik AJ; Zinner MJ; Ashley SW; McFadden DW
Am Surg; 1996 Mar; 62(3):232-6. PubMed ID: 8607584
[TBL] [Abstract][Full Text] [Related]
14. Peptide YY augments postprandial small intestinal absorption in the conscious dog.
Bilchik AJ; Hines OJ; Zinner MJ; Adrian TE; Berger JJ; Ashley SW; McFadden DW
Am J Surg; 1994 Jun; 167(6):570-4. PubMed ID: 8209930
[TBL] [Abstract][Full Text] [Related]
15. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
Eissele R; Koop H; Arnold R
Z Gastroenterol; 1990 Mar; 28(3):129-31. PubMed ID: 1971469
[TBL] [Abstract][Full Text] [Related]
16. Peptide YY does not inhibit glucose-stimulated insulin secretion in humans.
Ahren B; Larsson H
Eur J Endocrinol; 1996 Mar; 134(3):362-5. PubMed ID: 8616536
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
[TBL] [Abstract][Full Text] [Related]
18. PYY inhibition of VIP-stimulated ion transport in the rabbit distal ileum.
Quin JA; Sgambati SA; Goldenring JR; Basson MD; Fielding LP; Modlin IM; Ballantyne GH
J Surg Res; 1995 Jan; 58(1):111-5. PubMed ID: 7830399
[TBL] [Abstract][Full Text] [Related]
19. Distribution and postprandial release of porcine peptide YY.
Adrian TE; Bacarese-Hamilton AJ; Smith HA; Chohan P; Manolas KJ; Bloom SR
J Endocrinol; 1987 Apr; 113(1):11-4. PubMed ID: 3585220
[TBL] [Abstract][Full Text] [Related]
20. Suppression of peptide YY-induced hyperphagia by terbutaline.
Hagan MM; Moss DE
Pharmacol Biochem Behav; 1993 Nov; 46(3):679-81. PubMed ID: 7904074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
